Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

New EFdA prodrugs synthesized at GlaxoSmithKline

March 3, 2021

Activation of CARD8 inflammasome triggers pyroptosis of HIV-1-infected cells

Feb. 24, 2021

Clinical study provides proof of principle for HIV vaccine candidate eOD-GT8 60mer

Feb. 5, 2021

California Institute of Technology, Rockefeller University describe anti-HIV vaccine antibodies

Feb. 4, 2021

CD40-targeting vaccine enhances T- and B-cell responses against HIV-1

Feb. 2, 2021

Merck & Co. presents preliminary safety and PK data for islatravir in HIV-1 pre-exposure prophylaxis

Jan. 28, 2021

NIAID reports phase IIb results on VRC-01 for HIV prevention

Jan. 27, 2021

FDA approves Cabenuva long-acting regimen for HIV-1 infection in adults

Jan. 22, 2021

A humanized mouse HIV latency model to test HIV cure strategies

Jan. 12, 2021

ViiV Healthcare discovers compounds for HIV infection

Jan. 8, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...